In a xenograft model, intraperitoneal (i.p.)injection of ANGII significantly increases the tumorigenicity and metastasis of ovarian cancer cells, whereas an AGTR1 antagonist, losartan, suppresses this effect. Here, AGTR1 is linked to ovarian carcinoma.